PF-00956980
PF-00956980 is a reversible pan-JAK inhibitor with IC50 values of 2.2, 23.1 and 59.9 μM for JAK1, JAK2 and JAK3, respectively. PF-00956980 can be used in the research of lung and skin inflammatory diseases[1].
Product Specifications
CAS Number
1262832-74-5
UNSPSC
12352005
Target
JAK
Type
Reference compound
Related Pathways
Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/pf-00956980.html
Solubility
10 mM in DMSO
Smiles
O=C(N1C[C@H](N(C)C2=C3C(NC=C3)=NC=N2)[C@H](C)CC1)N4CCCC4
Molecular Formula
C18H26N6O
Molecular Weight
342.44
References & Citations
[1]Peter Jones, et al. Design and Synthesis of a Pan-Janus Kinase Inhibitor Clinical Candidate (PF-06263276) Suitable for Inhaled and Topical Delivery for the Treatment of Inflammatory Diseases of the Lungs and Skin. J Med Chem. 2017 Jan 26;60 (2) :767-786.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
JAK1; JAK2; JAK3
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb2328607-01 20 µg
Recombinant human FGFR2 Protein, C-His (HEK293)
Sign In for Pricing
View Details orb2328607-02 50 µg
Recombinant human FGFR2 Protein, C-His (HEK293)
Sign In for Pricing
View Details